VITEX Appoints New Member to Board of Directors

WATERTOWN, Mass--VI Technologies (VITEX) has announced the appointment of Joseph M. Limber to its Board of Directors.

Limber, currently the president and CEO of ACLARA BioSciences, Inc., has 25 years of biotechnology and pharmaceutical management experience.

VITEX is a biotechnology company responsible for developing products that inactive and remove pathogens in blood. Using nucleic acid chemistry, the company produced Inactine Pathogen Inactivation. The technology inactivates blood-borne viruses and bacteria and is in Phase II of clinical trials.